Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Comment by Homestretch4meon Nov 08, 2020 6:50pm
123 Views
Post# 31860077

RE:RE:RE:RE:RE:Funny Board

RE:RE:RE:RE:RE:Funny Board

So what you are saying is you don't know Aphria's US entry plan. I can't blame you because there is none.

I'm sure Constellation would pick Aphria over Canopy if they could go back and do it again but then again Aphria's management team got caught with their hands in the cookie jar and got punished for it.

Credentials??? If you have any credentials I hope nobody is paying you for advice. Anyways, when you finally get the Aphria US plan, we'll all be here waiting for you to enlighten us with your wisdom.

IrishCanuck wrote: Good call Kingbear, I actually wan't even going to go into the "Canopy acquire Aphria" rumour and Simon's shot across the bow how "if Constellation were to have a repeat they would have invested in Aphia comment" 


But to Stretch, this is my respons to you: 
Oh wow, so you're even more aggressive than your first post eh? Time to get high on your own supply and chill out man lol 

You're throwing out all these statements like they're proving Canopy is superior to Aphria but your whole thesis comes down to one thing: Canopy would be a failed company if it were not for Constellation bailing them out. I understand what Canopy is doing, their market will just not materialize as quickly as projected. Canopy will be fine, and both these companies will be around years from now, I'm not saying either are going bankrupt lmao In the world of stocks as this board is about it is most upside and least downside of assets you currently have so yes Aphria is better than Canopy right now. Who will be BIGGER in the future? Maybe Canopy sure but that's not equating to you making more money

And you're trying to be a macho man trying to flex as if you understand the business segment better than me? LOL I'm not evening going to get into credentials, so I'll leave it at how two people in an industry can still disagree...

And I can't type out Aphria's whole conference call and plan, like grow up you little man. All those licenses you're trying to flex do not equally translate to weed being legal at a federal level. They may provide nothing in the future other than a jump start... So I will repeat Aphria will adjust their business plan according to materialization of the US market rather than be tied down to a partner's business plan (i.e. Constellation) for a structure that may not be optimal


<< Previous
Bullboard Posts
Next >>